Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Con Edison to Report 2nd Quarter 2018 Earnings on August 2

13h globenewswire
NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) -- Consolidated Edison, Inc. (Con Edison) (NYSE:ED) plans to report its 2nd Quarter 2018 earnings on August 2, 2018 after the market closes.
ED

12
What JPMorgan, Fastenal, CASS And The DoT Are Saying To Buy

2018-07-16 seekingalpha
Multiple economic players and observers are singing the same song: the US economy is acting well despite Federal Reserve rates hikes.
PANW MS.PRE RCL MS.PRF FDX NFLX CCL MS.PRG PCAR MS.PRA CMI V MS.PRI BK MS.PRK CASS AAPL CCL CELG MS ED IVZ

15
Bert's June Dividend Income Summary

2018-07-12 seekingalpha
Half of 2018 is officially in the books! I am also another year older and have one year left to enjoy my 20s. 2018 has been an investing year unlike any other in the past. There have been a ton of great buying opportunities and companies are providing shareholders with some crazy dividend increases and share buyback programs. Lanny and I are having a blast following the twists and turns of Mr. Market.
PM SBUX ED

58
Top 10 Of 53 Dividend Aristocrats Yield 3.4%-6.2% In July Update

2018-07-11 seekingalpha
The 53 Aristocrats stocks represent all 11 Morningstar sectors. Broker target top 10 net gains ranged from 12.8% to 20.6%.
APD XOM WBA KMB PEP JNJ CVX DOV ABBV CAH ED ABBV MCD

3
Sell Tesla: Wall Street pulls out the rarest of ratings for Elon Musk

2018-07-07 nzherald.co.nz
Elon Musk is on Twitter scolding news organisations for quoting analysts with a bearish view of Tesla Inc. There are a lot to choose from.
UA TMK TMK.PRC TMK.PRB UAA AAPL ED TMK

1
Sell Tesla: Wall Street pulls out the rarest of ratings for Musk

2018-07-07 theage.com.au
Elon Musk is on Twitter scolding news organisations for quoting analysts with a bearish view of Tesla. There are a lot to choose from.
UA UAA ED

1
Sell Tesla: Wall Street pulls out the rarest of ratings for Musk

2018-07-07 smh.com.au
Elon Musk is on Twitter scolding news organisations for quoting analysts with a bearish view of Tesla. There are a lot to choose from.
UA UAA ED

3
Sell Tesla: Wall Street Pulls Out the Rarest of Ratings for Musk - Bloomberg

2018-07-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
UA TMK TMK.PRC TMK.PRB UAA AAPL ED TMK

82
Retirement Income (Part 2): I Am Building A Retirement Income Fund - Here Is What I Am NOT Doing

2018-07-02 seekingalpha
In the first article of this series, the current interest rate environment was described as it impacts significantly long-term investments being made today in that environment.
LOW FRT SPG.PRJ JNJ ADP KO BEN GPC EMR SPG ED MCD

93
July 2018 Stock Considerations

2018-07-02 seekingalpha
Here we are with another installment of my "stock considerations" for the upcoming month. With the first week of trading upon us in July, it is time, once again, to lay out a plan for my potential stock pick(s) for the month. As many of you already know, I make sure to purchase at least one stock every single month, no matter where we are in a business or macroeconomic cycle. The goal of every long-term dividend growth investor is to remain consistent with their buys and try not to attempt to time the market and wait for the "best" possible time to invest.
SOJA HCN PM GIS HCP WELL.PRI LTC SBRA WELL CAH ED JCI SBRAP VTR SO GE GEC D HCN.PRJ KMB HCN.PRI PEP KHC GNE SBUX CLX

77
Global Recession Risk Rising

2018-06-27 seekingalpha
Global recession risk rises as both China and Europe warn of collateral damage from trade tariffs.
SOJA GEO EPR.PRG O.PRF CTL LTC BATS 4162 OPRF SUI.PRA VZA SUI MSCA HMNY ED MO GOV SO ARCC O MAIN RMR GOVNI ARU MSCA.CL VGR T ROKU CLDT VZ WPC OHI

0
Bert's Recent Buy - Consolidated Edison

2018-06-26 seekingalpha
Lanny and I were painting the Dividend Diplomats' headquarters last week (aka - his house). He left to take a quick water break and came back pretty excited. When he gets this tone in his voice, I know that only means one thing…. there is a great stock that's price is falling. He brought up the fact that Consolidated Edison's (NYSE:ED) stock price was down over 1.5% that day. Instantly I was excited because ED is one of our Top 5 Foundation stocks.
ED

5
UPDATE 1-U.S. court order stops some work on Mountain Valley natgas pipeline in W. Virginia

2018-06-25 reuters
June 25 (Reuters) - EQT Midstream Partners will stop construction in West Virginia of parts of its $3.5 billion Mountain Valley natural gas pipeline after a U.S. federal appeals court issued an order last week against a permit, a U.S. regulator and the company said.
NEE.PRI NEE.PRJ EQM NEE.PRC NEE.PRQ WGL NEE.PRR ED RGCO NEE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

4h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

5h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ED / Consolidated Edison, Inc. on message board site Silicon Investor.

Franklin, Andrews, Kramer u0026 Edelstein Formerly About Advanced Micro Devices
Qualcomm Moderated Thread - please read rules before posting Golf! A thread for the hopelessly addicted!
Politics for Pros- moderated Immunomedics (IMMU) - moderated
OLED Universal Display Corp Laughter is the Best Medicine - Tell us a joke
International Automated Systems Anything graphite based, CCB, Zen and hopefully much more.
CUSIP: 209115104